✦ LIBER ✦

UP-3.104: Advances in Clinical Studies of Selective Serotonin Reuptake Inhibitor Treatment for Premature Ejaculation

✍ Scribed by L. Qiang

Book ID: 116951025
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 148 KB
Volume: 74
Category: Article
ISSN: 0090-4295
DOI: 10.1016/j.urology.2009.07.108

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Combination therapy with selective serot

Combination therapy with selective serotonin reuptake inhibitors and phosphodiesterase-5 inhibitors in the treatment of premature ejaculation

✍ Polat, E. C.; Ozbek, E.; Otunctemur, A.; Ozcan, L.; Simsek, A. 📂 Article 📅 2014 🏛 John Wiley and Sons 🌐 English ⚖ 104 KB

Deleterious effects of selective seroton

Deleterious effects of selective serotonin reuptake inhibitor treatment on semen parameters in patients with lifelong premature ejaculation

✍ Koyuncu, H; Serefoglu, E C; Ozdemir, A T; Hellstrom, W J 📂 Article 📅 2012 🏛 Nature Publishing Group 🌐 English ⚖ 141 KB

MP48-18 COMPARISON OF PAROXETINE AND DAP

MP48-18 COMPARISON OF PAROXETINE AND DAPOXETINE, A NOVEL SELECTIVE SEROTONIN REUPTAKE INHIBITOR, IN THE TREATMENT OF PREMATURE EJACULATION

✍ Simsek, Abdulmuttalip; Sarilar, Omer; Kirecci, Sinan; Kucuktopcu, Onur; Ozgor, F 📂 Article 📅 2014 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 43 KB

Analysis of association between the 5-HT

Analysis of association between the 5-HTTLPR and STin2 polymorphisms in the serotonin-transporter gene and clinical response to a selective serotonin reuptake inhibitor (sertraline) in patients with premature ejaculation

✍ Mohammad Reza Safarinejad 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 224 KB

POD-09.01: Analysis of Association Betwe

POD-09.01: Analysis of Association Between the 5-HTTLPR and Stin2 Polymorphisms in the Serotonin Transporter Gene and Clinical Response to Selective Serotonin Reuptake Inhibitor (Sertraline) in Patients with Premature Ejaculation

✍ M. Safarinejad 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 121 KB

5031 Overall response rate (ORR) and cli

5031 Overall response rate (ORR) and clinical benefit (CB) as clinical indicators for the efficacy of sequential Aromatase Inhibitors (AIs) in 3rd line hormonal treatment (HT) for advanced breast cancer (ABC): pooled analysis of phase II studies

✍ V. Vaccaro; E. Bria; F. Cuppone; M. Milella; C. Nisticò; I. Sperduti; D. Giannar 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 47 KB